PRELUDE CAPITAL MANAGEMENT, LLC - UROVANT SCIENCES LTD ownership

UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 41 filers reported holding UROVANT SCIENCES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of UROVANT SCIENCES LTD
ValueSharesWeighting
Q4 2020$3,986,000
+398500.0%
247,148
+537178.3%
0.10%
Q4 2019$1,000
-50.0%
46
-72.3%
0.00%
Q3 2019$2,0000.0%166
-44.7%
0.00%
Q2 2019$2,0000.0%300
+55.4%
0.00%
Q1 2019$2,000
+100.0%
193
-11.9%
0.00%
Q4 2018$1,000
-99.8%
219
-99.3%
0.00%
-100.0%
Q3 2018$402,00033,4630.02%
Other shareholders

There were no reported owners of UROVANT SCIENCES LTD in Q4 2020.

NameSharesValueWeighting ↓
View complete list of UROVANT SCIENCES LTD shareholders